Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I

Blood. 1998 Nov 15;92(10):3557-61.

Abstract

The presence of circulating "flower cells" and a low prevalence of antibody to Tax regulatory protein of human T-lymphotropic virus type I (HTLV-I) are characteristics of adult T-cell leukemia (ATL). To examine the predictability of levels of HTLV-I antibodies and of flower cell-like abnormal lymphocytes (Ably) for the risk of ATL among asymptomatic HTLV-I carriers, we prospectively evaluated the levels of viral markers of five HTLV-I carriers who developed ATL and 38 age-, sex-, and screen-matched HTLV-I-positive controls in the Miyazaki Cohort Study. After accounting for matching factors, Ably level was slightly, but not significantly, higher among cases than among controls (P =.13). Anti-HTLV-I (odds ratio [OR] = 1.6 per twofold dilution; 95% confidence interval [CI] 0.94, 3.8) was associated with ATL diagnosis, but antibody to Tax regulatory protein (anti-Tax) was not (OR = 0.78; 95% CI 0.26, 1.7). Anti-Tax level was low for all ATL cases for up to 10 years preceding their diagnosis, independent of the level of anti-HTLV-I titer. HTLV-I carriers with a higher anti-HTLV-I titer and a lower anti-Tax reactivity may be at greatest risk of ATL.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor
  • Carrier State / blood
  • Carrier State / epidemiology*
  • Carrier State / immunology
  • Cohort Studies
  • Female
  • Gene Products, tax / immunology
  • HTLV-I Antibodies / blood
  • HTLV-I Antibodies / immunology
  • HTLV-I Infections / blood
  • HTLV-I Infections / epidemiology*
  • HTLV-I Infections / immunology
  • Human T-lymphotropic virus 1 / immunology
  • Humans
  • Japan / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / blood
  • Leukemia-Lymphoma, Adult T-Cell / epidemiology*
  • Leukemia-Lymphoma, Adult T-Cell / immunology
  • Male
  • Middle Aged
  • Neoplastic Stem Cells / pathology
  • Prospective Studies
  • Risk Factors
  • Smoking / epidemiology
  • T-Lymphocytes / pathology

Substances

  • Biomarkers, Tumor
  • Gene Products, tax
  • HTLV-I Antibodies